211 filings
Page 4 of 11
424B5
s4vsls9zf
28 Feb 22
Prospectus supplement for primary offering
5:12pm
S-8
7lxmt04as0imsmu52z0
28 Feb 22
Registration of securities for employees
4:32pm
8-K
jjaqyi
28 Feb 22
Mersana Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
6:16am
8-K
ax8p9my4l
3 Feb 22
Entry into a Material Definitive Agreement
7:15am
8-K
gk0spgj7df5xwv icis
23 Nov 21
Entry into a Material Definitive Agreement
7:16am
EFFECT
23ztd946e 39iyjyi3
19 Nov 21
Notice of effectiveness
12:15am
CORRESP
z7cbu8w
16 Nov 21
Correspondence with SEC
12:00am
UPLOAD
b77dic7bmojhxe0 8elq
15 Nov 21
Letter from SEC
12:00am
8-K
9i4c lpm3f
9 Nov 21
Mersana Therapeutics Announces Third Quarter 2021 Financial Results and Provides Business Update
6:15am
8-K
sq7sx4la
29 Oct 21
Entry into a Material Definitive Agreement
5:25pm
8-K
xnvsh1wu0e1
10 Sep 21
Other Events
7:50am
8-K
0629k
16 Aug 21
Mersana Therapeutics Announces Appointment of Tushar Misra, Ph.D., as Chief Manufacturing Officer
8:16am
8-K
srdne5r2arj9x0zh4
6 Aug 21
Mersana Therapeutics Announces Second Quarter 2021 Financial Results and Provides Business Update
6:30am
8-K
ibune5
17 Jun 21
Submission of Matters to a Vote of Security Holders
6:30am
S-8
aje4x10y 0ffrwg
10 May 21
Registration of securities for employees
5:20pm
8-K
2sdssq5rv4qf7es2
10 May 21
Mersana Therapeutics Announces First Quarter 2021 Financial Results and Provides Business Update
5:00pm